Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Gene expression variability across cells and species shapes innate immunity.

Hagai T, Chen X, Miragaia RJ, Rostom R, Gomes T, Kunowska N, Henriksson J, Park JE, Proserpio V, Donati G, Bossini-Castillo L, Vieira Braga FA, Naamati G, Fletcher J, Stephenson E, Vegh P, Trynka G, Kondova I, Dennis M, Haniffa M, Nourmohammad A, Lässig M, Teichmann SA.

Nature. 2018 Nov;563(7730):197-202. doi: 10.1038/s41586-018-0657-2. Epub 2018 Oct 24.

2.

The impact of single-cell RNA sequencing on understanding the functional organization of the immune system.

Vegh P, Haniffa M.

Brief Funct Genomics. 2018 Jul 1;17(4):265-272. doi: 10.1093/bfgp/ely003. Review.

3.

MicroRNA profiling of the bovine alveolar macrophage response to Mycobacterium bovis infection suggests pathogen survival is enhanced by microRNA regulation of endocytosis and lysosome trafficking.

Vegh P, Magee DA, Nalpas NC, Bryan K, McCabe MS, Browne JA, Conlon KM, Gordon SV, Bradley DG, MacHugh DE, Lynn DJ.

Tuberculosis (Edinb). 2015 Jan;95(1):60-7.

4.

The Role of microRNAs in Bovine Infection and Immunity.

Lawless N, Vegh P, O'Farrelly C, Lynn DJ.

Front Immunol. 2014 Nov 27;5:611. doi: 10.3389/fimmu.2014.00611. eCollection 2014. Review.

5.

Profiling microRNA expression in bovine alveolar macrophages using RNA-seq.

Vegh P, Foroushani AB, Magee DA, McCabe MS, Browne JA, Nalpas NC, Conlon KM, Gordon SV, Bradley DG, MacHugh DE, Lynn DJ.

Vet Immunol Immunopathol. 2013 Oct 1;155(4):238-44. doi: 10.1016/j.vetimm.2013.08.004. Epub 2013 Aug 24.

PMID:
24021155
6.

Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays.

Papp K, Végh P, Hóbor R, Szittner Z, Vokó Z, Podani J, Czirják L, Prechl J.

PLoS One. 2012;7(9):e44824. doi: 10.1371/journal.pone.0044824. Epub 2012 Sep 11.

7.

Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays.

Papp K, Végh P, Hóbor R, Erdei A, Prechl J.

J Immunol Methods. 2012 Jan 31;375(1-2):75-83. doi: 10.1016/j.jim.2011.09.009. Epub 2011 Oct 5.

PMID:
22000977
8.

Lineage divergence at the first TCR-dependent checkpoint: preferential γδ and impaired αβ T cell development in nonobese diabetic mice.

Feng N, Vegh P, Rothenberg EV, Yui MA.

J Immunol. 2011 Jan 15;186(2):826-37. doi: 10.4049/jimmunol.1002630. Epub 2010 Dec 10.

9.

Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice.

Papp K, Végh P, Tchorbanov A, Vassilev T, Erdei A, Prechl J.

Rheumatology (Oxford). 2010 Dec;49(12):2273-80. doi: 10.1093/rheumatology/keq278. Epub 2010 Aug 24.

PMID:
20736228
10.

Conventional chromogenic heparin assays are influenced by patient's endogenous plasma Antithrombin levels.

Mitchell LG, Vegh P.

Klin Padiatr. 2010 May;222(3):164-7. doi: 10.1055/s-0030-1251988. Epub 2010 May 31.

PMID:
20514621
11.

Long-term "in vitro" proliferating mouse hematopoietic progenitor cell lines.

Vegh P, Winckler J, Melchers F.

Immunol Lett. 2010 May 4;130(1-2):32-5. doi: 10.1016/j.imlet.2010.02.001. Epub 2010 Feb 17.

PMID:
20170678
12.
13.

B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.

Papp K, Végh P, Prechl J, Kerekes K, Kovács J, Csikós G, Bajtay Z, Erdei A.

Mol Immunol. 2008 Apr;45(8):2343-51. doi: 10.1016/j.molimm.2007.11.021. Epub 2008 Jan 14.

PMID:
18192019
14.

Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.

Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Lau A, Mitchell LG.

Haematologica. 2007 Apr;92(4):554-7.

15.
16.

Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.

Kuhle S, Lau A, Bajzar L, Vegh P, Halton J, Cherrick I, Anderson R, Desai S, McCusker P, Wu J, Abshire T, Mahoney D, Mitchell L.

Br J Haematol. 2006 Sep;134(5):526-31.

PMID:
16856890
17.

Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events.

Kuhle S, Massicotte P, Dinyari M, Vegh P, Mitchell D, Marzinotto V, Chan A, Pieniaszek H, Mitchell LG.

Thromb Haemost. 2005 Dec;94(6):1164-71.

PMID:
16411388
18.

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.

Male C, Foulon D, Hoogendoorn H, Vegh P, Silverman E, David M, Mitchell L.

Blood. 2005 Dec 15;106(13):4152-8. Epub 2005 Sep 6.

19.

Acetyl:succinate CoA-transferase in procyclic Trypanosoma brucei. Gene identification and role in carbohydrate metabolism.

Rivière L, van Weelden SW, Glass P, Vegh P, Coustou V, Biran M, van Hellemond JJ, Bringaud F, Tielens AG, Boshart M.

J Biol Chem. 2004 Oct 29;279(44):45337-46. Epub 2004 Aug 23.

20.

Kinetic energy release of protonated methanol clusters using the low-temperature fast-atom bombardment: experiment and theory combined.

Gömöry A, Végh P, Sztáray J, Drahos L, Vékey K.

Eur J Mass Spectrom (Chichester). 2004;10(2):213-20.

PMID:
15103098
21.

Low-temperature SIMS mass spectra of diethyl ether.

Kosevich MV, Shelkovsky VS, Boryak OA, Gömöry A, Végh PD, Vékey K.

J Mass Spectrom. 2003 May;38(5):517-22.

PMID:
12794872
22.

Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease.

Albisetti M, Chan AK, McCrindle BW, Wong D, Vegh P, Adams M, Dinyari M, Monagle P, Andrew M.

Blood Coagul Fibrinolysis. 2003 Feb;14(2):181-6.

PMID:
12632029
23.

Fibrinolytic system in adolescents: response to venous occlusion stress tests.

Monagle P, Chan AK, Albisetti M, Vegh P, Andrew M, Mitchell L.

Pediatr Res. 2003 Feb;53(2):333-7.

PMID:
12538795
24.
25.

Pathophysiological effects of human TNF-alpha-producing tumor xenografts in immunosuppressed mice.

Nagy T, Jánossy T, Vizler C, Bohus K, Joó F, Végh P, Duda E.

APMIS. 1999 Oct;107(10):903-12.

PMID:
10549587
26.

Prothrombotic disorders in infants and children with cerebral thromboembolism.

deVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S, Vegh P, Adams M, Marzinotto V, Leaker M, Massicotte MP, Lillicrap D, Andrew M.

Arch Neurol. 1998 Dec;55(12):1539-43.

PMID:
9865798
27.

Enhanced thrombin regulation during warfarin therapy in children compared to adults.

Massicotte P, Leaker M, Marzinotto V, Adams M, Freedom R, Williams W, Vegh P, Berry L, Shah B, Andrew M.

Thromb Haemost. 1998 Oct;80(4):570-4.

PMID:
9798971
28.

The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.

Berube C, Mitchell L, Silverman E, David M, Saint Cyr C, Laxer R, Adams M, Vegh P, Andrew M.

Pediatr Res. 1998 Sep;44(3):351-6.

PMID:
9727712
29.

Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin.

Monagle P, Andrew M, Halton J, Marlar R, Jardine L, Vegh P, Johnston M, Webber C, Massicotte MP.

Thromb Haemost. 1998 Apr;79(4):756-61.

PMID:
9569188
30.

Host-versus-graft disease in mice after the induction of neonatal transplantation tolerance by two different methods.

Pipis J, Jánossy T, Modok S, Ocsovszki I, Hidvégi Z, Horváth G, Végh P, Benner R.

Acta Chir Hung. 1997;36(1-4):280-1.

PMID:
9408374
31.

Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigens.

Jánossy T, Vizler C, Ocsovszki I, Tibbe GJ, Pipis J, Savelkoul HF, Végh P, Benner R.

Acta Chir Hung. 1997;36(1-4):150-1.

PMID:
9408323
32.

Induction and analysis of lethal graft-versus-host disease in tolerant mice.

Végh P, Vizler C, Jánossy T, Savelkoul HF, Nyirati I, Benner R.

Transplant Proc. 1996 Jun;28(3):1241-3. No abstract available.

PMID:
8658641
33.

Circulating dermatan sulfate and heparan sulfate/heparin proteoglycans in children undergoing liver transplantation.

Mitchell L, Superina R, Delorme M, Vegh P, Berry L, Hoogendoorn H, Andrew M.

Thromb Haemost. 1995 Sep;74(3):859-63.

PMID:
8571311
34.

Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor.

Massicotte P, Marzinotto V, Vegh P, Adams M, Andrew M.

J Pediatr. 1995 Sep;127(3):389-94.

PMID:
7658268
36.

Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.

Jánossy T, Baranyi L, Vizler C, Nyirati I, Végh P.

Transplant Proc. 1995 Feb;27(1):188-90. No abstract available.

PMID:
7878968
37.

Thrombin regulation in children differs from adults in the absence and presence of heparin.

Andrew M, Mitchell L, Vegh P, Ofosu F.

Thromb Haemost. 1994 Dec;72(6):836-42.

PMID:
7740451
38.

Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase.

Halton JM, Mitchell LG, Vegh P, Eves M, Andrew ME.

Am J Hematol. 1994 Nov;47(3):157-61.

PMID:
7524313
39.

Lack of cross-species sensitization between skin allo- and xenotransplants in mice.

Vizler C, Jánossy T, Tabi Z, Végh P.

Transplant Proc. 1994 Jun;26(3):1324-5. No abstract available.

PMID:
8029925
40.

Long-term survival and use of human skin xenografts in immunosuppressed mice.

Jánossy T, Vizler C, Krizsa J, Hunyadi J, Kiss M, Nyirati I, Dobozy A, Végh P.

Transplant Proc. 1994 Jun;26(3):1268-70. No abstract available.

PMID:
8029904
41.

Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.

Mitchell LG, Halton JM, Vegh PA, Barr RD, Venneri T, Pai KM, Andrew ME.

Am J Pediatr Hematol Oncol. 1994 May;16(2):120-6.

PMID:
8166364
43.

Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.

Jánossy T, Baranyi L, Knulst AC, Vizler C, Benner R, Kelényi G, Végh P.

Eur J Immunol. 1993 Nov;23(11):3011-20.

PMID:
8223878
44.

A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants.

Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, Watts J, Saigal S, Milner R, Wang E.

J Pediatr. 1993 Aug;123(2):285-91.

PMID:
8345429
45.
46.

Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?

Schmidt B, Vegh P, Johnston M, Andrew M, Weitz J.

Thromb Haemost. 1993 May 3;69(5):418-21.

PMID:
8322263
47.

A comparative study of heel-stick devices for infant blood collection.

Paes B, Janes M, Vegh P, LaDuca F, Andrew M.

Am J Dis Child. 1993 Mar;147(3):346-8.

PMID:
8438824
48.

Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.

Vizler C, Jánossy T, Baranyi L, Végh P.

Cell Immunol. 1993 Feb;146(2):431-7.

PMID:
8174181
49.

Maturation of the hemostatic system during childhood.

Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L.

Blood. 1992 Oct 15;80(8):1998-2005.

50.

Coagulation screening tests in high risk neonates: a prospective cohort study.

Schmidt BK, Vegh P, Andrew M, Johnston M.

Arch Dis Child. 1992 Oct;67(10 Spec No):1196-7.

Supplemental Content

Support Center